Potassium Cl 2meq/ml Inj 20ml

Manufacturer FRESENIUS KABI Active Ingredient Potassium Chloride Injection Solution(poe TASS ee um KLOR ide) Pronunciation Poe TASS ee um KLOR ide
It is used to treat or prevent low potassium levels.
đŸˇī¸
Drug Class
Electrolyte, Mineral Supplement
đŸ§Ŧ
Pharmacologic Class
Electrolyte replacement
🤰
Pregnancy Category
C
✅
FDA Approved
Jan 1970
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Potassium chloride is a medicine given through a vein (intravenously) to replace potassium in your body when your levels are too low. Potassium is a very important mineral that helps your heart, muscles, and nerves work properly. Low potassium can cause serious problems, including heart rhythm issues.
📋

How to Use This Medicine

To use this medication correctly, follow your doctor's instructions and carefully read all accompanying information. Take this medication exactly as directed, and adhere to all guidelines provided. This drug is administered as an intravenous infusion, which means it is given through a vein over a specified period of time.

If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage procedure.

In the event that you miss a dose, contact your doctor immediately to receive guidance on the appropriate course of action.
💡

Lifestyle & Tips

  • This medication is given in a hospital or clinic setting. You will be monitored closely during and after the infusion.
  • Report any unusual symptoms immediately, such as muscle weakness, tingling, numbness, or a feeling of your heart racing or skipping beats.
  • Follow your doctor's instructions regarding diet and other medications, especially if you are also taking diuretics or heart medications.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Individualized based on serum potassium levels and clinical condition. For mild to moderate hypokalemia, 20-40 mEq IV over 2-4 hours. For severe hypokalemia, up to 10 mEq/hour, not exceeding 200 mEq/day. Maximum concentration for peripheral infusion is typically 40 mEq/L; higher concentrations (up to 80 mEq/L) may be used via central line with extreme caution.
Dose Range: 10 - 200 mg

Condition-Specific Dosing:

severe_hypokalemia: Up to 10 mEq/hour, with continuous ECG monitoring. Higher rates (e.g., 20 mEq/hour) may be used in life-threatening situations (e.g., cardiac arrhythmias) in an ICU setting with continuous cardiac monitoring and frequent potassium level checks.
cardiac_arrest_with_hyperkalemia: Not applicable, Potassium Chloride is contraindicated in hyperkalemia.
đŸ‘ļ

Pediatric Dosing

Neonatal: 0.5-1 mEq/kg/dose IV over 1-2 hours, not to exceed 0.5 mEq/kg/hour. Max concentration 40 mEq/L.
Infant: 0.5-1 mEq/kg/dose IV over 1-2 hours, not to exceed 0.5 mEq/kg/hour. Max concentration 40 mEq/L.
Child: 0.5-1 mEq/kg/dose IV over 1-2 hours, not to exceed 0.5 mEq/kg/hour. Max concentration 40 mEq/L. Max daily dose 3 mEq/kg or 40 mEq/m2.
Adolescent: Similar to adult dosing, individualized based on weight and potassium deficit, typically 0.5-1 mEq/kg/dose, not exceeding 10 mEq/hour.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: Use with caution; monitor serum potassium and renal function closely.
Moderate: Reduce dose and/or frequency; monitor serum potassium and renal function very closely. Consider lower maximum infusion rates (e.g., 5 mEq/hour).
Severe: Contraindicated in severe renal impairment (e.g., anuria, oliguria, acute renal failure) due to high risk of hyperkalemia. If absolutely necessary, use extremely low doses with continuous ECG and frequent potassium monitoring.
Dialysis: Generally contraindicated in patients on dialysis unless specifically indicated to correct severe hypokalemia, and only under strict medical supervision with frequent monitoring. Dialysis itself can remove potassium.

Hepatic Impairment:

Mild: No specific dose adjustment required.
Moderate: No specific dose adjustment required.
Severe: No specific dose adjustment required, but monitor for conditions that may affect potassium balance (e.g., ascites, diuretic use).

Pharmacology

đŸ”Ŧ

Mechanism of Action

Potassium is the principal intracellular cation. It plays a fundamental role in numerous physiological processes, including the maintenance of intracellular tonicity, nerve impulse transmission, muscle contraction (especially cardiac muscle), and the maintenance of normal renal function. It is also involved in carbohydrate metabolism and protein synthesis. Potassium chloride injection provides exogenous potassium to correct hypokalemia (low potassium levels) and maintain normal potassium balance.
📊

Pharmacokinetics

Absorption:

Bioavailability: 100% (intravenous administration)
Tmax: Immediate (upon completion of infusion)
FoodEffect: Not applicable (IV administration)

Distribution:

Vd: Approximately 0.5 L/kg (reflects total body water, with 98% intracellular)
ProteinBinding: Negligible
CnssPenetration: Limited (maintains concentration gradient)

Elimination:

HalfLife: Variable, depends on renal function and potassium balance. Under normal conditions, plasma half-life is short as it rapidly moves into cells or is excreted.
Clearance: Primarily renal clearance, regulated by aldosterone and acid-base status.
ExcretionRoute: Renal (glomerular filtration and tubular secretion), small amounts via feces and sweat.
Unchanged: 100%
âąī¸

Pharmacodynamics

OnsetOfAction: Rapid (within minutes of IV infusion initiation)
PeakEffect: Rapid (shortly after infusion, as plasma levels rise)
DurationOfAction: Variable, depends on the underlying cause of hypokalemia, renal function, and ongoing losses. Effects persist as long as potassium levels are maintained within the normal range.

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high potassium levels, including:
+ Abnormal heartbeat
+ Confusion
+ Weakness, lightheadedness, or dizziness
+ Feeling like passing out
+ Numbness or tingling
+ Shortness of breath
Slow heartbeat
Chest pain or pressure
Signs of low sodium levels, such as:
+ Headache
+ Difficulty focusing
+ Memory problems
+ Confusion
+ Weakness
+ Seizures
+ Changes in balance
Shortness of breath, significant weight gain, or swelling in the arms or legs
* If the medication leaks from the vein, it may cause tissue damage. Inform your nurse immediately if you experience:
+ Redness
+ Burning
+ Pain
+ Swelling
+ Blisters
+ Skin sores
+ Leaking of fluid at the injection site

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people may not experience any side effects or only minor ones. If you have side effects that bother you or persist, contact your doctor or seek medical attention.

Please note that this list is not exhaustive. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe muscle weakness or paralysis
  • Numbness or tingling in hands, feet, or lips
  • Slow, fast, or irregular heartbeat (palpitations)
  • Shortness of breath
  • Chest pain
  • Confusion
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
If you have high potassium levels in your blood.
* If you are currently taking any of the following medications: Amiloride, Eplerenone, Spironolactone, or Triamterene.

Please note that this is not an exhaustive list of all potential interactions. Therefore, it is crucial to discuss all of your medications, including prescription and over-the-counter drugs, natural products, and vitamins, with your doctor and pharmacist. This will help ensure that it is safe to take this medication in conjunction with your other treatments and health conditions.

Remember, before starting, stopping, or adjusting the dose of any medication, you must consult with your doctor to avoid potential interactions or complications.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Regular blood tests will be necessary, as directed by your doctor, to monitor your condition. Be sure to discuss any concerns or questions with your doctor.

To minimize the risk of severe side effects, it is crucial to adhere to the prescribed dosage and not exceed the amount recommended by your doctor. If you follow a low-salt diet or use a salt substitute, consult with your doctor to discuss any potential interactions.

Certain formulations of this medication may not be suitable for children, so it is essential to consult with your doctor if you have any questions or concerns. Additionally, if you are pregnant, planning to become pregnant, or breastfeeding, you should discuss the potential benefits and risks of this medication with your doctor to make an informed decision about your treatment.
🆘

Overdose Information

Overdose Symptoms:

  • Hyperkalemia (high potassium levels)
  • Muscle weakness, flaccid paralysis
  • Paresthesias (tingling, numbness)
  • Bradycardia (slow heart rate)
  • Hypotension (low blood pressure)
  • Cardiac arrhythmias (e.g., peaked T waves, widened QRS, ventricular fibrillation, asystole)
  • Cardiac arrest

What to Do:

Immediate medical emergency. Call 911 or emergency services. Treatment involves immediate cessation of potassium infusion, administration of calcium gluconate (to stabilize cardiac membrane), insulin and glucose (to shift potassium into cells), sodium bicarbonate (for acidosis), and potentially diuretics or potassium-binding resins. Hemodialysis may be required in severe, refractory cases. Call 1-800-222-1222 (Poison Control).

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride) - concurrent use significantly increases risk of severe hyperkalemia.
  • Patients with hyperkalemia or conditions predisposing to hyperkalemia (e.g., severe renal impairment, acute dehydration, extensive tissue breakdown, adrenal insufficiency).
🔴

Major Interactions

  • ACE inhibitors (e.g., lisinopril, enalapril) - may cause hyperkalemia by reducing aldosterone secretion.
  • Angiotensin Receptor Blockers (ARBs) (e.g., valsartan, losartan) - similar to ACE inhibitors, may cause hyperkalemia.
  • NSAIDs (e.g., ibuprofen, naproxen) - may impair renal potassium excretion, increasing hyperkalemia risk.
  • Cyclosporine, Tacrolimus - may cause hyperkalemia.
  • Trimethoprim - can cause hyperkalemia by acting as a potassium-sparing diuretic.
🟡

Moderate Interactions

  • Digoxin - hypokalemia increases digoxin toxicity; hyperkalemia can reduce digoxin efficacy. Careful monitoring of potassium levels is crucial.
  • Beta-blockers (non-selective) - may impair cellular uptake of potassium, potentially leading to higher extracellular potassium.
  • Heparin - can cause hypoaldosteronism, leading to hyperkalemia.
  • Succinylcholine - may cause a transient increase in serum potassium, especially in patients with pre-existing hyperkalemia or conditions like burns/trauma.
đŸŸĸ

Minor Interactions

  • Certain laxatives (e.g., stimulant laxatives) - chronic abuse can lead to potassium depletion, requiring potassium supplementation.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Serum Potassium

Rationale: To determine the degree of hypokalemia and guide initial dosing.

Timing: Prior to initiation of therapy.

Renal Function (BUN, Creatinine, GFR)

Rationale: Potassium is primarily excreted by the kidneys; impaired renal function increases risk of hyperkalemia.

Timing: Prior to initiation of therapy.

Electrocardiogram (ECG)

Rationale: To assess for cardiac manifestations of hypokalemia (e.g., flattened T waves, U waves, ST depression, arrhythmias) and to monitor for signs of hyperkalemia during infusion (e.g., peaked T waves, widened QRS, prolonged PR interval).

Timing: Prior to initiation, and continuously during rapid or high-dose infusions.

Other Electrolytes (Magnesium, Calcium, Phosphate)

Rationale: Hypokalemia often coexists with other electrolyte imbalances, particularly hypomagnesemia, which can make potassium repletion difficult.

Timing: Prior to initiation of therapy.

📊

Routine Monitoring

Serum Potassium

Frequency: Every 2-4 hours during active repletion, then daily or as clinically indicated once stable.

Target: 3.5-5.0 mEq/L

Action Threshold: If potassium rises above 5.0 mEq/L, slow or stop infusion. If below 3.5 mEq/L, continue or adjust infusion rate/dose.

Electrocardiogram (ECG)

Frequency: Continuous monitoring during rapid or high-dose infusions; periodically during slower infusions.

Target: Normal cardiac rhythm and morphology.

Action Threshold: Any signs of hyperkalemia (peaked T waves, widened QRS, prolonged PR) or significant arrhythmias require immediate cessation of infusion and intervention.

Fluid Balance (Intake/Output)

Frequency: Every 4-8 hours.

Target: Appropriate for patient's clinical status.

Action Threshold: Significant changes in urine output may indicate changes in renal function affecting potassium excretion.

Infusion Site

Frequency: Regularly (e.g., every 1-2 hours) during infusion.

Target: No signs of pain, redness, swelling, or extravasation.

Action Threshold: Signs of phlebitis or extravasation require immediate cessation of infusion and site care.

đŸ‘ī¸

Symptom Monitoring

  • Muscle weakness
  • Fatigue
  • Muscle cramps
  • Paresthesias (tingling, numbness)
  • Palpitations or irregular heartbeat
  • Shortness of breath
  • Nausea, vomiting, abdominal discomfort
  • Confusion or altered mental status

Special Patient Groups

🤰

Pregnancy

Category C. Potassium is an essential electrolyte. While animal reproduction studies have not been conducted, and there are no adequate and well-controlled studies in pregnant women, potassium supplementation is often necessary to correct maternal hypokalemia, which can be detrimental to both mother and fetus. Use only if clearly needed and the potential benefit outweighs the potential risk to the fetus.

Trimester-Specific Risks:

First Trimester: No specific increased risk identified beyond general electrolyte balance.
Second Trimester: No specific increased risk identified beyond general electrolyte balance.
Third Trimester: No specific increased risk identified beyond general electrolyte balance. Close monitoring of maternal potassium levels is crucial, especially if diuretics are also used.
🤱

Lactation

L1 (Safest). Potassium is a natural component of breast milk and is essential for infant growth and development. Exogenous potassium administered to the mother is unlikely to cause adverse effects in a breastfed infant when administered appropriately to correct maternal deficiency. The amount transferred into breast milk is not expected to be harmful.

Infant Risk: Low risk.
đŸ‘ļ

Pediatric Use

Dosing must be carefully calculated based on weight (mEq/kg) and clinical status. Infusion rates should be slow, typically not exceeding 0.5 mEq/kg/hour. Continuous ECG monitoring is often recommended, especially for higher rates or severe hypokalemia. Risk of hyperkalemia is higher in neonates and infants due to immature renal function.

👴

Geriatric Use

Elderly patients are at increased risk for renal impairment, which can significantly reduce potassium excretion and increase the risk of hyperkalemia. They may also be on multiple medications (e.g., ACE inhibitors, ARBs, NSAIDs) that can affect potassium levels. Close monitoring of renal function, serum potassium, and ECG is essential. Start with lower doses and slower infusion rates.

Clinical Information

💎

Clinical Pearls

  • NEVER administer Potassium Chloride Injection undiluted or as an IV push. Rapid administration can be fatal.
  • Always dilute potassium chloride in a large volume of IV fluid (e.g., D5W, NS) before administration.
  • Maximum recommended concentration for peripheral infusion is typically 40 mEq/L to minimize vein irritation and phlebitis. Higher concentrations (up to 80 mEq/L) should only be administered via a central venous catheter.
  • Maximum infusion rate should generally not exceed 10 mEq/hour in adults, except in life-threatening situations with continuous cardiac monitoring in an ICU setting.
  • Correct hypomagnesemia concurrently, as magnesium is required for cellular potassium uptake and retention.
  • Monitor serum potassium levels frequently during and after infusion, along with renal function and ECG.
  • Patients with renal impairment are at significantly increased risk of hyperkalemia; use with extreme caution or avoid.
  • Be aware of drug interactions that can increase potassium levels (e.g., ACE inhibitors, ARBs, potassium-sparing diuretics).
🔄

Alternative Therapies

  • Oral potassium supplements (e.g., potassium chloride tablets, liquid) for mild to moderate hypokalemia or for maintenance therapy.
  • Potassium-rich foods (e.g., bananas, oranges, potatoes, leafy greens) for dietary management of mild hypokalemia.
💰

Cost & Coverage

Average Cost: $5 - $20 per 20ml vial (2meq/ml)
Generic Available: Yes
Insurance Coverage: Tier 1 (Preferred Generic)
📚

General Drug Facts

If your symptoms or health problems persist or worsen, it is essential to contact your doctor for further guidance. To ensure your safety and the safety of others, never share your medication with anyone, and do not take medication prescribed for someone else.

All medications should be stored in a secure location, out of the reach of children and pets, to prevent accidental ingestion. When disposing of unused or expired medications, do not flush them down the toilet or pour them down the drain unless specifically instructed to do so by a healthcare professional or pharmacist. Instead, consult with your pharmacist to determine the best disposal method, as some communities have drug take-back programs.

Additionally, some medications may come with a separate patient information leaflet; if you have questions, consult with your pharmacist. If you have any concerns or questions about your medication, it is crucial to discuss them with your doctor, nurse, pharmacist, or other healthcare provider.

In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. Be prepared to provide information about the medication taken, the quantity, and the time it was taken, as this will aid in providing appropriate care.